Efficacy of Compounds Isolated from <i>Streptomyces olivaceus</i> against the Morphogenesis and Virulence of <i>Candida albicans</i>

<i>Candida albicans</i> is a type of commensal fungi which causes serious infections in immunocompromised patients and contributes to high mortality. In the present study, we identified that the extract from <i>Streptomyces olivaceus</i> SCSIO T05 inhibited hypha and biofilm...

詳細記述

書誌詳細
主要な著者: Lili Meng, Changli Sun, Chunyan Zhang, Shihao Song, Xiuyun Sun, Jianhua Ju, Yinyue Deng
フォーマット: 論文
言語:English
出版事項: MDPI AG 2019-07-01
シリーズ:Marine Drugs
主題:
オンライン・アクセス:https://www.mdpi.com/1660-3397/17/8/442
その他の書誌記述
要約:<i>Candida albicans</i> is a type of commensal fungi which causes serious infections in immunocompromised patients and contributes to high mortality. In the present study, we identified that the extract from <i>Streptomyces olivaceus</i> SCSIO T05 inhibited hypha and biofilm formation of <i>C. albicans</i>. Seven compounds were isolated and evaluated for their effects on the biological functions and virulence of <i>C. albicans</i>. Two leading compounds, compound <b>1</b> (sorbicillin) and compound <b>2</b> (3-methyl-<i>N</i>-(2&#8242;-phenethyl)-butyrylamide) were identified as exhibiting strong activity against <i>C. albicans</i> morphological transition, adhesion activity, cytotoxicity, and adhesion to human cells, in a dose-dependent manner. Notably, compound <b>2</b> inhibited <i>C. albicans</i> infection in mouse oral mucosal models. Transcriptomic analysis and real-time PCR results revealed that compound <b>2</b> most likely inhibited the biological functions of <i>C. albicans</i> cells by regulating the expression levels of <i>HWP1</i>, <i>TEC1</i>, <i>ALS1</i>, <i>IFD6</i>, and <i>CSH1</i>, which are associated with filament formation and cell adhesion. Our results suggest that the candidate compounds present excellent efficacy against <i>C. albicans</i> pathogenicity and that they can be developed as potential options for the clinical treatment of candidiasis.
ISSN:1660-3397